Phibro Animal Health Corporation
NASDAQPhibro Animal Health Corporation reports today against a backdrop defined by one number above all others: the May earnings print, which sent the stock down 32% in a single session and 38% over the following five days. With the stock now trading at $36.09 — having clawed back roughly 6% over the past month — the question heading into today's release is how much of the recovery…
Snapshot as of 20 Sept 2026
Phibro Animal Health Corporation reports today against a backdrop defined by one number above all others: the May earnings print, which sent the stock down 32% in a single session and 38% over the following five days.…
Phibro Animal Health heads into the final stretch before its August 26 earnings with short sellers rebuilding positions and options traders pricing in more downside protection than usual. The most striking move this…
Phibro Animal Health Corporation heads into its May 7 earnings call with the CEO selling shares almost every trading day of the past two weeks — even as the stock surged to new highs. The insider angle is the story…
Phibro Animal Health just reported fiscal Q3 results that beat on both top and bottom lines — and promptly raised full-year guidance — yet the CEO has spent the past two weeks trimming his position into every…
Phibro Animal Health Corporation reports its Q3 2026 results today, and the most conspicuous signal heading into the print is not a short seller — it's the CEO. Jack Bendheim, who controls 48% of the company, sold…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PAHC — free to start on ORTEX.
Sign up for free →Open PAHC on ORTEX